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Abstract
Genetic studies in Drosophila melanogaster underscore the importance of the insulin-signalling pathway
in controlling cell, organ and animal size. Effectors of this pathway include Chico (the insulin receptor
substrate homologue), dPI(3)K, dPKB, dPTEN, and dS6K. Mutations in any of these components have a
striking effect on cell size and number, with the exception of dS6K. Mutants in dS6K affect cell size but
not cell number, seemingly consistent with arguments that dS6K is a distal effector in the signalling
pathway, directly controlled by dTOR, a downstream effector of dPI(3)K and dPKB. Unexpectedly,
recent studies showed that dS6K activity is unimpaired in chico-deficient larvae, suggesting that dS6K
activation may be mediated through the dPI(3)K docking sites of the Drosophila insulin receptor. Here,
we show genetically, pharmacologically and biochemically that dS6K resides on an insulin signalling
pathway distinct from that of dPKB, and surprisingly also from that of dPI(3)K. More striking, despite
dPKB-dPI(3)K-independence, dS6K activity is dependent on the Drosophila homologue of the
phosphoinositide-dependent protein kinase 1, dPDK1, demonstrating that both dPDK1, as well as
dTOR, mediated dS6K activation is phosphatidylinositide-3,4,5-trisphosphate (PIP3)-independent.
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Genetic studies in Drosophila melanogaster underscore the
importance of the insulin-signalling pathway in controlling
cell, organ and animal size1. Effectors of this pathway
include Chico (the insulin receptor substrate homologue),
dPI(3)K, dPKB, dPTEN, and dS6K2. Mutations in any of
these components have a striking effect on cell size and
number3–7, with the exception of dS6K8. Mutants in dS6K
affect cell size but not cell number, seemingly consistent
with arguments that dS6K is a distal effector in the sig-
nalling pathway, directly controlled by dTOR, a downstream
effector of dPI(3)K and dPKB1,9,10. Unexpectedly, recent
studies showed that dS6K activity is unimpaired in chico-
deficient larvae, suggesting that dS6K activation may be
mediated through the dPI(3)K docking sites of the
Drosophila insulin receptor11. Here, we show genetically,
pharmacologically and biochemically that dS6K resides on
an insulin signalling pathway distinct from that of dPKB, and
surprisingly also from that of dPI(3)K. More striking, despite
dPKB-dPI(3)K-independence, dS6K activity is dependent on
the Drosophila homologue of the phosphoinositide-
dependent protein kinase 1, dPDK1, demonstrating that
both dPDK1, as well as dTOR, mediated dS6K activation
is phosphatidylinositide-3,4,5-trisphosphate (PIP3)–
independent.
Insulin-induced dS6K activation has been depicted as being trig-gered by dPI(3)K activation, either through chico, or directlythrough multiple dPI(3)K-SH2 docking sites in the extended tail
of the Drosophila insulin receptor1. Activation of dPI(3)K induces
increased levels of PIP3, which in turn functions as a second mes-
senger to mediate dPDK1 and dPKB activation. Based on studies in
mammalian systems12–14, dPDK1 is thought to directly phosphory-
late the activation loop site of dPKB, as well as that of dS6K13,14. In
contrast to dPDK1, dPKB is thought to exert its effects on dS6K
indirectly, by mediating dTOR activation15, which in turn controls
the phosphorylation of key residues at the carboxyl tail of dS6K16.
However, recent studies have shown that dTOR lacks the PKB
phosphorylation sites that were argued to mediate mammalian
TOR (mTOR) activation11,17. In addition, studies in mammalian
systems have suggested that PKB may be part of a parallel pathway
to that of S6K, instead of functioning as an upstream effector18. To
examine the function of dPDK1 and dPKB in the control of dS6K
function, we employed a dS6K-dependent phenotype in the wing8.
Selective overexpression of an upstream activation sequence
(UAS)-dS6K transgene under the control of the apterous-GAL4
driver (ap-GAL4) in the dorsal compartment of the wing causes a
bending down of the wing, presumably because of an increased size
of cells on the dorsal surface (Fig. 1a). Expression of dPDK1 or
dPKB, driven by the same ap-GAL4-UAS system, has no effect on
the wing (Fig. 1b). In contrast, co-expression of dS6K with dPDK1
strongly enhances the bent wing phenotype achieved with dS6K
alone, whereas co-expression of dPKB with dS6K consistently led to
a slight suppression of the dS6K phenotype (Fig. 1b), possibly
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Figure 1 Genetic interaction analysis between dS6K and either dPDK1 or
dPKB. a, Expression of an extra copy of dS6K in the dorsal wing imaginal disc
compartment causes the adult wing to bend downwards. b, Frontal view of analysis
of genetic interactions in the dorsal wing compartment using the ap-GAL4–UAS-
dS6K-sensitized wing phenotype.
© 2003 Nature Publishing Group
brief communications
NATURE CELL BIOLOGY VOL 4 MARCH 2002 http://cellbio.nature.com252
because of the titration of GAL4 or dPDK1. In agreement with the
dS6K–dPDK1 genetic interaction, the dS6K bent wing phenotype is
suppressed in a hypomorphic-mutated dPDK1 genetic back-
ground19. These findings are compatible with dPDK1 as an
upstream effector of dS6K and favour a model where dPKB func-
tions on a distinct signalling pathway to that of dS6K, rather than
as an upstream effector of dS6K.
To determine whether the absence of an epistatic interaction
between dS6K and dPKB had a biochemical basis, dS6K and dPKB
activity were measured in either Drosophila cells deprived of amino
acids, which blocks mammalian S6K but not PKB activation20, or in
larvae deficient in functional dPKB21. dS6K and dPKB activity were
analysed on western blots with phosphospecific antibodies that rec-
ognize dS6K-T398 (ref. 11) or dPKB-S505 (ref. 22) phosphoryla-
tion sites, respectively, or in immune complex assays with either
40S ribosomal protein S6 (ref. 11) or the synthetic peptide
‘Crosstide’ as substrates22. In Drosophila Kc167 cells, amino acid
deprivation blocks insulin-induced dS6K-T398 phosphorylation
and dS6K activation (Fig. 2a), whereas it does not alter insulin-
induced dPKB-S505 phosphorylation or dPKB activation
(Fig. 2a,b). In contrast, amino acids alone stimulate dS6K activa-
tion, an effect that is significantly potentiated by insulin, but do not
induce dPKB-S505 phosphorylation or dPKB activation (Fig. 2a,b).
Thus, amino acid-induced dS6K activation is dPKB-independent.
To ascertain the function of dPKB in mediating dS6K activation in
the intact animal, extracts from wild type and mutant dS6K, chico,
and dTOR second-instar larvae were assayed for dS6K and dPKB
activity, and these results were compared with those obtained with
mutant dPKB second-instar larvae. It should be noted, that the
activity of endogenous dPKB in larval extracts was too low to be
resolved by the conventional assay, therefore it was necessary to
separate the phosphorylated Crosstide on thin layer plates (see
Methods). As previously reported11, there is a severe reduction in
dS6K activity in extracts from either larvae null for dS6K or mutant
for dTOR, whereas dS6K activity was unaffected in chico null
mutants (Fig. 2c and 2d). In the latter case, it should be noted that
we could not detect Chico protein by western blot analysis (data
not shown). Despite the absence of dS6K activity in the dTOR
mutants, there was no effect on dS6K activity in extracts from
dPKB mutant larvae (Fig. 2c), which are devoid of dPKB activity
(Fig. 2d and ref. 22). Consistent with the possibility that the
extended tail of the Drosophila insulin receptor is sufficient to
recruit dPI(3)K, dPKB activity was normal in chico mutants
(Fig. 2d). Unlike chico mutants, larvae lacking dS6K or dTOR func-
tion had elevated levels of dPKB activity, compatible with recent
studies showing that mTOR functions in a negative feedback loop
to dampen insulin-induced PKB activation in adipocytes23 (Fig.
2d). The differences were not because of variations in protein load-
ing, as shown by western blotting of the same extracts with either
dS6K, Drosophila initiation factor 4E or dPKB antibodies (Fig. 2c
and 2d). That dS6K activity is unaffected in extracts from dPKB
mutant larvae, whereas in dTOR mutants it is abolished, argues
against dPKB mediating dTOR-dS6K activation in the fly.
The results above show that neither chico nor dPKB are neces-
sary to mediate dS6K activation, and support a model where
dPI(3)K activation of dS6K is mediated directly through dPI(3)K
docking sites of the Drosophila insulin receptor, in a dPKB-inde-
pendent manner11. To investigate whether this is the case, Kc167
cells were treated in culture with insulin alone or in the presence of
the fungal metabolite wortmannin, an inhibitor of PI(3)K activity,
or the rapamycin derivative RAD001 (ref. 24), an inhibitor of
mTOR activity. The results show that insulin stimulation leads to a
potent increase in dS6K-T398 and dPKB-S505 phosphorylation
(Fig. 3a) and activation of both kinases (Figs 3a–c). As expected,
dPKB-S505 phosphorylation and activation were abolished by
wortmannin treatment (Fig. 3a–c) and were potentiated by
RAD001, compatible with the data from larvae lacking dS6K or
dTOR (Fig. 2d). Surprisingly, neither dS6K activation nor dS6K-
T398 phosphorylation are affected by wortmannin, although dS6K
activation is blocked by RAD001 (Fig. 3a,b). These findings imply
that dS6K activation is independent of increases in PIP3 levels. To
ensure that PIP3 levels are diminished by wortmannin treatment,
they were measured in a radioligand displacement assay25. The
results show that insulin induces a sharp increase in PIP3 levels, an
effect that is almost totally inhibited by wortmannin (Fig. 3d), con-
sistent with the block of dPKB activation by the inhibitor (Fig. 3a,c).
Taken together, these findings strongly imply that neither PI(3)K,
nor increased production of PIP3 is necessary for dS6K activation.
The findings above were unexpected and could be unique for
Kc167 cells. To assess this possibility, the capacity of the Drosophila
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Figure 2 dS6K activation is dependent on amino acids and dTOR, but inde-
pendent of dPKB. a, Activation of dS6K by mitogens in Drosophila Kc167 cells
requires the presence of amino acids, in contrast to dPKB activation. Cells were
incubated in the presence or absence of amino acids and with or without insulin
treatment (100 nM, 30 min). A representative autoradiograph of the in vitro dS6K
activity assay (top). Detection of dS6K-Thr 398 and dPKB-Ser 505 phosphorylation
with phosphosite-specific antibodies (bottom). b, dPKB activity was assayed with
Crosstide as a substrate. c, Measurement of dS6K activity in larvae. Genotypes are
indicated above the lanes. A representative autoradiograph of the in vitro dS6K
activity assay (top). dS6K and eIF4E protein levels (bottom). Similar results were
obtained in at least three independent experiments. d, Measurement of dPKB activi-
ty in larvae. Genotypes are indicated above the lanes. A representative phosphorim-
age of the in vitro dPKB activity assay (top). 32P-CT, 32P-Crosstide. dPKB protein lev-
els (bottom). Similar results were obtained in two independent experiments.
© 2003 Nature Publishing Group
brief communications
NATURE CELL BIOLOGY VOL 4 MARCH 2002 http://cellbio.nature.com 253
PI(3)K class IA catalytic subunit, Dp110 (ref. 4), to modify dS6K
function, either genetically or biochemically, was analysed in the
animal. In the eye imaginal disc, the GMR promoter was used to
drive GAL4 expression posterior to the morphogenetic furrow6.
Eyes expressing UAS-Dp110 were significantly larger in size
(Fig. 4a), because of an increased ommatidia size (Fig. 4b), where-
as those expressing UAS-dS6K and UAS-dPKB were either normal
or slightly larger, respectively (Fig. 4a,b and ref. 26). Co-expression
of Dp110 with dS6K caused no further enlargement of the eye, but
co-expression with dPKB induced a clear increase in the size of the
eye and individual ommatidia (Fig. 4a,b). In the wing, ap-GAL4-
driven UAS-Dp110 expression caused dramatic overgrowth, inhibit-
ing wing unfolding and precluding analysis of genetic interactions
(data not shown). To circumvent this problem the MS1096-GAL4
driver was utilized, which drives expression in both compartments
of the wing disc, but more strongly in the dorsal compartment.
Under these conditions, increased expression of Dp110 caused the
wing to bend slightly downwards4. Co-expression of Dp110 with
UAS-dPKB bent the wing strongly downwards, whereas co-expres-
sion with UAS-dS6K caused no modification of the phenotype
(Fig. 4c). Consistent with these findings, enlarged eye and omma-
tidia size induced by expression of UAS-Dp110 under control of the
GMR-GAL4 promoter was not affected in flies lacking dS6K. By
contrast, the effect of UAS-Dp110 in the eye was completely sup-
pressed in a viable hypomorphic dPKB mutant background
(Fig. 4d, and H.S. and E.H., unpublished data). Thus, at the genet-
ic level dPKB acts as a key effector of dPI(3)K-driven growth in the
compound eye and the wing, whereas dS6K does not cooperate
genetically with dPI(3)K to increase growth in either of these two
compartments. The mechanisms by which dPI(3)K and dPKB stim-
ulate growth remain to be defined, but may involve the alteration of
translation rates by phosphorylation of Drosophila glycogen syn-
thase kinase-3 (dGSK-3) and Drosophila translation initiation fac-
tor 4E binding protein (d4E-BP)27.
The data shown above imply that dPI(3)K does not signal to
dS6K in Drosophila. To analyse this point biochemically, dS6K and
dPKB activity were monitored in second-instar larvae of Dp110-
null mutants, Dp110A, which fail to develop beyond early third lar-
val instar28. The results show that dS6K activity was unaffected in
such larvae, whereas dPKB activity was abolished (Fig. 4e), consis-
tent with the data from cells in culture and genetic interactions in
the wing and the eye. However, despite the absence of a require-
ment for dPI(3)K function in dS6K activation, an epistatic interac-
tion was detected between dPDK1 and dS6K in the wing (Fig. 1b).
In addition, previous studies have shown that mammalian PDK1
regulates the critical activation loop phosphorylation site in mam-
malian S6K1, Thr 229 (refs 13,14). To determine whether the
absence of dPDK1 function had an effect on dPKB and dS6K, the
activity of both kinases was analysed in dPDK1 mutant second-
instar larvae, which have a stop codon just upstream of the highly
conserved APE motif within kinase domain VIII, eliminating sub-
strate recognition19. Unexpectedly, dPKB activity was unaffected in
such larvae (Fig. 4e), compatible with findings in mammalian cells
that other kinases can modulate activation loop phosphorylation29
or with findings that phosphorylation of the hydrophobic site is
sufficient to induce PKB activation30. Consistent with the latter
finding, hyperphosphorylation of dPKB-S505 is observed in
extracts of dPDK1 mutant larvae, as well as in dPKB mutant larvae
(Fig. 4e). By contrast, dS6K activity in extracts from dPDK1 mutant
second-instar larvae was reduced to a similar extent, as observed in
dTOR mutant second-instar larvae (compare Figs 4f and 2c). Thus,
even though dPI(3)K function is not required for dS6K activation,
dPDK1 is critical for this response.
The results presented here demonstrate that dPDK1, independ-
ently of dPI(3)K, is an upstream effector of dS6K, consistent with
studies in mammalian cells showing that PDK1-mediated activa-
tion loop phosphorylation of S6K1 is independent of PI(3)K13,14.
Earlier studies also showed that PDK1 activity is constitutive in
resting cells and refractive to insulin stimulation12,13. Thus, for
PDK1 to access the S6K1 activation loop site, it only requires phos-
phorylation of key residues at the carboxyl tail of S6K1 by
mTOR13,16. The findings obtained here strongly imply that the
phosphorylation of these C-terminal residues in dS6K by dTOR is
not mediated by the dPI(3)K-signalling pathway. One possibility is
that dTOR mediates the phosphorylation of these sites as a func-
tion of increased nutrient uptake after insulin stimulation (see
Supplementary information, Fig. S1). Admittedly, flies may utilize a
distinct pathway for dS6K activation, however models placing S6K
downstream of PI(3)K in mammalian systems also have been ques-
tioned31. It may be that activated alleles of PI(3)K, which activate
S6K1, do not reflect endogenous wild type PI(3)K signalling, as
recently shown for activated alleles of PKB18. The importance of
understanding these links is underscored by recent studies showing
that dS6K is epistatically dominant to the Drosophila orthologues of
the human tumour suppressor genes tuberous sclerosis 1 and 2 (Tsc1
and Tsc2)32, whereas dTsc1 and dTsc2 are epistatically dominant to
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Figure 3 dS6K activation in Drosophila Kc167 cells does not require
increased PIP3 levels. a, A representative autoradiograph of the dS6K activity
assay (top). Detection of dS6K-Thr 398 and dPKB-Ser 505 phosphorylation with
phosphospecific antibodies (bottom). RAD, RAD001; WM, wortmannin. b, dS6K
activity measured in vitro with 40S ribosomal protein S6 as substrate. c, dPKB
activity assayed with Crosstide as a substrate. Values in b and c represent means
of three independent experiments. d, Fold stimulation of PIP3 production in Kc167
cells (values represent means of triplicate experiments).
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other components of the insulin signalling pathway10.
Furthermore, rapamycin has proven efficacious in the treatment of
solid tumours33 and many of the inhibitory effects of rapamycin on
larval growth are rescued by overexpression of dS6K17. Thus,
Drosophila may prove a useful tool in elucidating the molecular
mechanisms by which mTOR/S6K activation is mediated in the
normal and transformed phenotypic setting.
Methods
Drosophila strains and genetic interactions
The genetic background for all mutant flies used was y w, all crosses were set at 25 °C and phenotypic
analysis was done with females. dPDK1 corresponds to Dstpk61 (ref. 34). Null alleles used were: dS6Kl-1 8,
chico (ref. 3), dPDK15 19, dTOR2L19 11 and Dp110A 28. dTOR2L1 and dPKB1 (Dakt1q) encode kinase-dead
proteins11,21. The ap-GAL4 driver was used to express the UAS-transgene in the dorsal wing compart-
ment8 and a recombined ap-GAL4 UAS-dS6K / CyO line was used for the co-expression experiments.
UAS-dPKB transgenic flies and the dPKB3 allele will be described elsewhere (H.S. and E.H., unpub-
lished data). The dPDK1-overexpressing line corresponds to the EP(3)837 strain35. GMR-GAL4 UAS-
Dp110 and MS-1096 UAS-Dp110 transgenic flies were described previously4. Scanning electron
microscopy (SEM) was performed in the REM-Labor Pharmazentrum, University Basel, by cryoprepa-
ration with Baltec SCU020 attached to Jeol 6300 LaB6 (Peabody, MA).
Cell culture
Drosophila embryo-derived Kc167 cells were maintained as described36. Before experiments, the cells
were grown to stationary phase. RAD001, a rapamycin derivative currently in clinical trials for the pre-
vention of graft rejection after allotransplantation, was added 15 min before insulin treatment, at a
final concentration of 20 nM. Wortmannin (Sigma) was added 30 min before insulin treatment, at a
final concentration of 100 nM. Bovine insulin (Calbiochem, San Diego, CA) was applied at 100 nM for
30 min. For amino acid starvation, cells were transferred to medium devoid of amino acids for 30 min
before treatments.
dS6K and dPKB activity measurements
Mutant larvae were balanced over the T(2; 3)L14, SM5–TM6B translocation to allow selection of
homozygous-mutated early second-instar larvae. The larvae were transferred to squashed fresh fly food
(30 ml yeast cornmeal molasses) supplemented with 1 ml water. Batches of 20 late second-instar larvae
were collected, washed, transferred to an Eppendorf tube and frozen in liquid nitrogen. Larvae or
Kc167 cells were extracted and dS6K activity was measured, essentially as described11,36. 32P radioactivi-
ty incorporated into ribosomal protein S6 was quantified with Molecular Dynamics Image Quant soft-
ware (Molecular Dynamics, Sunnyvale, CA) dPKB was immunoprecipitated from cell extracts
(200 µg total protein) with 2 µg polyclonal dPKB antibody37. For larval extracts, 350 µg total protein
and 3 µg of antibody were used. dPKB activity was assayed by incubating the immune complexes
with 30 µM Crosstide for 30 min (1 h for larval assays) at 30 °C. 32P radioactivity incorporated into the
peptide was quantified with a Scintillation counter (Packard) in the Cherenkov mode. For measure-
ment of dPKB activity in larvae, the supernatant of the kinase assay reaction was dried in a speedvac,
10 µl of pH 1.9 buffer [2.5% formic acid, 7.8% acetic acid] was added and then spotted onto a thin
layer chromatography (TLC) plate. The Crosstide was separated from unincorporated radioactivity by
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Figure 4 dS6K activation in Drosophila is dPI(3)K independent but requires
dPDK1. a, SEMs of eyes (same magnification). Scale bar represents 100 µm.
Genotypes are indicated. b, SEMs of ommatidia from eyes as in a. Scale bar repre-
sents 10 µm. Values represent average ommatidia size in percent (compared to
GMR-GAL4). c, Frontal view of genetic interaction analysis in the wing. d,
Overexpression of Dp110 in the eye induces overgrowth in the absence of dS6K
(top) but not in a background with reduced dPKB function (bottom). Scale bar,
100 µm. Genotypes are indicated. Insets show SEMs of the ommatidia. Values rep-
resent average ommatidia size in percent (compared to GMR-GAL4 in b). Scale bar
represents 10 µm. e, Left panels: measurement of dSK6 activity in larvae. A repre-
sentative autoradiograph of the dS6K activity assay (top). dS6K and eIF4E protein
levels (bottom). Similar results were obtained in at least three independent experi-
ments. Right panels: Measurement of dPKB activity in larvae. Representative phos-
phorimage of the in vitro dPKB activity assay (top). 32P-CT, 32P-Crosstide. dPKB
phospho-S505 and dPKB protein levels (bottom). Similar results were obtained in
two independent experiments. Genotypes are indicated above the lanes. f,
Measurement of dS6K activity in larvae, as described in e.
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thin layer electrophoresis (TLE) for 40 min at 1000 V (pH 1.9) and 32P-Crosstide was detected with a
phosphorimager.
Western blotting
dS6K, eIF4E and dPKB were detected with polyclonal antibodies, as previously described11,37.
Phosphospecific antibodies to S6K-T389 and PKB/Akt-S473 were purchased from New England
Biolabs (Beverly, MA). These antibodies crossreacted with the corresponding phosphoresidues in dS6K
and dPKB, respectively.
Phosphatidylinositide 3,4,5-trisphosphate (PIP3) measurements
After the indicated treatments, cells were pelleted and quenched with 1 ml of ice-cold 10% TCA.
Pellets were washed once with 0.75 ml 5% TCA/1 mM EDTA. Lipids were extracted according to the
Bligh & Dyer method, before alkaline hydrolysis. The released polar head groups were used in a radi-
oligand displacement assay25 with 33P-Ins (1,3,4,5)P4 (2500 Ci mmol
−1) and recombinant glutathione 
S-transferase (GST)-tagged Ras GTPase activating protein–inositol 1,3,4,5 tetraphosphate-binding
protein (GAP1–IP4BP), which binds Ins (1,3,4,5)P4 with high affinity and selectivity.
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supplementary infomation
1
Figure S1 Model of the signalling events leading to the activation of dS6K and
dPKB in Drosophila. Activation of dInR promotes nutrient uptake and induces PIP3 pro-
duction (counteracted by dPTEN) by dPI(3)K. Increased PIP3 at the membrane causes
membrane-translocation and activation of dPKB by a so far uncharacterised dPDK2 activi-
ty and dPDK1 (broken arrow indicates the uncertainty of the mechanism of dPKB activa-
tion in dPDK1 deficient larvae). Nutrient availability sensed via dTOR may prime dS6K for
full activation by a separate pool of dPDK1. Arrows indicate a positive input while bars
represent inhibition.
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